Concepedia

Publication | Open Access

Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

DOIFull Paper Access

1K

Citations

28

References

2002

Year

Hannelore Ehrenreich, Martin Hasselblatt, Christoph Dembowski, Lukas Cepek, Piotr Lewczuk, Michael Stiefel, Hans-Heino Rustenbeck, N Breiter, Sonja Jacob, Friederike Knerlich‐Lukoschus,
Molecular Medicine

Abstract

Intravenous high-dose rhEPO is well tolerated in acute ischemic stroke and associated with an improvement in clinical outcome at 1 month. A larger scale clinical trial is warranted.

References

YearCitations

Page 1